FDA Approved: AMPHETAMINE EXTENDED-RELEASE — Supplemental Application (Neos Therapeutics, LP)

View source ↗

Summary

The FDA approved a supplemental application for AMPHETAMINE EXTENDED-RELEASE from Neos Therapeutics, LP, updating the product through a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• AMPHETAMINE EXTENDED-RELEASE (Amphetamine extended-release)

Snippet

SUPPL AP for AMPHETAMINE EXTENDED-RELEASE (AMPHETAMINE EXTENDED-RELEASE)